GOP may renew fight over ACA repeal following McCain’s death

Amy Baxter | | Health Exec | Policy & Regulations

Congressional Republicans are reportedly thinking about taking another swing at overturning  the Affordable Care Act (ACA) after the death of Senator John McCain, R-Arizona, The Hill reported. 

McCain, who passed away of brain cancer on Aug. 25, argued for the Senate to return to "regular order" in the debate over ACA, before casting a deciding vote against repealing the healthcare law in July 2017. The dramatic vote, signaled by a thumbs-down by McCain on the Senate floor, came as a surprise to President Donald Trump and Republicans.

Following his death, Republicans are hopeful to take up their battle to overturn the ACA next year.

“If we re-engage in that discussion in some point in the future, it would be nice to have members who enable us to pass it,” Senate Republican Conference Chairman John Thune from South Dakota told The Hill.

See the full story below:

GOP eyes another shot at ObamaCare repeal after McCain’s death

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

OCR investigating Michigan health system over possible violation of 'Church Amendments'
PHOTO GALLERY: AMA House of Delegates meeting
Papers discussing ‘gender’ have been restored to government website
AMA agrees to help after initial request for an independent cardiovascular board was denied
AMA president warns prior authorization hurting patients, driving burnout and practice closures
Veterans Affairs denies it discriminates based on politics, marital status

Around the web

Cardiovascular Business
AMA agrees to help after initial request for an independent cardiovascular board was denied

After their proposal for a new American Board of Cardiovascular Medicine was shot down earlier this year, cardiology groups have asked the AMA for some support. "We feel like it's time for us to blaze our own path," one specialist explained. 

Cardiovascular Business
Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

Cardiovascular Business
AMA House of Delegates helps cardiology groups influence healthcare policies

American College of Cardiology Board of Governors Chair David E. Winchester, MD, MS, examines the many benefits of working with the American Medical Association House of Delegates to bring about significant change.